The Fujitsu Arrow Tab LTE F-01D is similar to many tablets currently on the market today. It has all the goodies like a 10.1-inch 1280 x 768 screen, a 1GHz dual-core processor, a pair of cameras, 16GB of storage, micro-USB, microSD card slot, and Android 3.2 Honeycomb. Now for the really cool stuff, itâ€™s waterproof and obeys gesture commands via its front facing camera.
I suppose this could really be cool tech for nursing or lab, but I thought it was worth having a deeper look.
The ReVac Retracting Safety Syring by Revolutions Medical â€œuse a proprietary patented technology in which a vacuum causes the needle to retract into the barrel of the syringe or device after an injection is administered or blood is drawn.â€
According to the Revolutions Medical website â€œ[t]he RevVacâ„¢ Safety Syringe and Phlebotomy (blood drawing) Device operate the same as a standard syringe and device. No additional training, skills, or procedures are necessary. The both products work on a vacuum principle, where pressing the plunger in them creates a vacuum. When the plunger reaches the bottom, the needle is captured. A further push on the plunger breaks the seal, and the needle retracts into the plunger barrel. The vacuum is maintained, so the needle cannot be removed from the plunger.â€
Boing Boing: â€œIn a very cool video from Chemical and Engineering News, Art Olson of the Scripps Research Institute explains how chemists in his lab can predict how well the drugs they develop will work.
Olson’s lab prints 3D models of molecular structures, both targetsâ€”like the HIV protease enzyme in the videoâ€”and the drugs they’ve made to bond to those targets. The models are rigged up so that when Olson holds them in front of a webcam, they instantly interact with chemical analysis software his team has built. The result is a system that allows researchers to see, physically, how well the drugs fit their targets, and simultaneously test how well the two are likely to bond on a chemical level.â€
A 3D printed molecule with augmented reality! This is downright awesome. Thereâ€™s no other way to say it. Drug development will never be the same. The only question I have isâ€¦ where can I get one for myself?
It warms the cockles of my heart to read stuff like this. The I.V. Compatibility module for Lexicomp is now available for the Android OS. I couldnâ€™t find any screen shots so youâ€™ll just have to use your imagination.
You can find more information here.
Lexicomp’s I.V. Compatibility module is now available for your Lexicomp On-Hand subscription for Androidâ„¢! By following the update instructions below, you can add this module to your existing Lexicomp On-Hand subscription. There is no additional charge for this enhancement.
The I.V. Compatibility module allows you to review compatibility and stability information for hundreds of parenteral medications and fluids. This module is based on information from the KingÂ® Guide to Parenteral AdmixturesÂ®. Thousands of clinicians are already using Lexicomp’s I.V. Compatibility module every day – now you can access this vital information on your Android smartphone or tablet as well.
To update your subscription to include I.V. Compatibility, follow these instructions:
Ensure you have a strong Wi-Fi or cellular connection.
On your Android device, tap the Market icon and search for Lexicomp.
Select Lexicomp and tap Update. When the warning appears, tap Accept & Download.
When the application is installed, tap the Lexicomp icon to access your software.
Iâ€™ve spent a fair amount of time in rental cars this year, and one thing I hate is trying to figure out the controls. They seem simple enough, except when youâ€™re in a hurry. Whether itâ€™s the cruise control, the wipers, environmental controls, the lights or the radio, it always takes me a while to get things ironed out. Kind of reminds me of the mess healthcare is in; you never know what systems youâ€™re going to get.
The Canadian Pharmacist Association is looking for a way to track drug shortages. They would like to get drug manufactures and hospitals to participate in a national reporting system. Itâ€™s a great idea and one that I think could provide value.